Fortune Sky is Your Go-to Source for the Latest Finance News, Covering Markets, Business, Industries and Internet.
⎯ 《 Fortune • Sky 》

Codetta Bio Appoints New Vice President of Product Management to Lead Commercial Strategy

2023-08-22 21:23
DURHAM, N.C.--(BUSINESS WIRE)--Aug 22, 2023--
Codetta Bio Appoints New Vice President of Product Management to Lead Commercial Strategy

DURHAM, N.C.--(BUSINESS WIRE)--Aug 22, 2023--

Codetta Bio, the life sciences company developing advanced multiomic biomarker measurement tools, announced today that Jeremy Lambert has joined the company as Vice President of Product Management. In this role, Lambert will lead the development and execution of Codetta’s commercial strategy as the company brings its breakthrough multiomic solution to market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230822205083/en/

Jeremy Lambert, Vice President of Product Management at Codetta Bio (Graphic: Business Wire)

“Jeremy has a proven track record as a strategic, customer and market-focused leader in life sciences technology product development,” said Anthony Lemmo, CEO of Codetta Bio. “Thanks to his broad knowledge of genomic and proteomic technology, Jeremy also has a clear understanding of the unique advantages of Codetta’s technology and its potential. I’m thrilled to welcome him to the team.”

Lambert joins Codetta with over 20 years of experience working in product development and commercialization of life science research technologies. Most recently, Lambert served as Vice President of Product Management at Quanterix, where during his tenure, the company grew from $12M to over $100M in revenue in protein biomarker measurement platforms. He has also held product marketing roles at several other life sciences technology companies including Caliper Life Sciences and PerkinElmer. Lambert has previously supported and led the identification, design, development, and marketing of various technology products in drug discovery and life sciences, with specific expertise in genomics and proteomics technology, instrumentation, reagents, and software.

“The data-driven insights that Codetta’s multiomic biomarker measurement tools can provide have the potential to uncover valuable information on diseases and help advance the research and development of new therapies,” said Lambert. “I’m looking forward to working alongside the rest of the Codetta team to develop a commercial strategy that will make our innovative solution widely accessible and ultimately improve outcomes for patients everywhere.”

To learn more about Codetta Bio, please visit http://www.codettabio.com.

About Codetta Bio
Codetta Bio is developing advanced multiomic biomarker measurement tools supporting data-driven approaches to understanding the unique genetic, environmental, lifestyle, and clinical factors that contribute to individual health and wellness. For more information, visit http://www.codettabio.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230822205083/en/

CONTACT: Media Contact

Brandon Reid for Codetta Bio

bwr@anzupartners.com

KEYWORD: UNITED STATES NORTH AMERICA NORTH CAROLINA

INDUSTRY KEYWORD: DATA MANAGEMENT TECHNOLOGY PROFESSIONAL SERVICES HEALTH GENERAL HEALTH HEALTH TECHNOLOGY OTHER SCIENCE OTHER TECHNOLOGY RESEARCH DATA ANALYTICS SCIENCE

SOURCE: Codetta Bio

Copyright Business Wire 2023.

PUB: 08/22/2023 09:00 AM/DISC: 08/22/2023 09:02 AM

http://www.businesswire.com/news/home/20230822205083/en